Management of High-Risk Localized Prostate Cancer
Traditionally, patients with high-risk localized prostate cancer have been an extremely challenging group to manage due to a significant likelihood of treatment failure and prostate cancer-specific mortality (PCSM). The results of multiple large, prospective, randomized trials have demonstrated that...
Saved in:
| Main Authors: | Ariel E. Marciscano, Matthew E. Hardee, Nicholas Sanfilippo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | Advances in Urology |
| Online Access: | http://dx.doi.org/10.1155/2012/641689 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Focal Therapy in the Management of Prostate Cancer: An Emerging Approach for Localized Prostate Cancer
by: Takeo Nomura, et al.
Published: (2012-01-01) -
PSMA PET/CT findings in high‐risk biochemical recurrence after local treatment of prostate cancer
by: Nicole Handa, et al.
Published: (2025-05-01) -
Apalutamide for high-risk localized prostate cancer following radical prostatectomy- A new Horizon
by: Mithilesh Yadav
Published: (2025-07-01) -
Genetic alterations of prostate cancer: in localized and metastatic prostate cancer
by: Chang Eil Yoon, et al.
Published: (2025-07-01) -
The Role of Pelvic Exenteration in the Management of Locally Advanced Prostate Cancer
by: Ala'a Farkouh, et al.
Published: (2022-05-01)